We have some exciting news to share! The Motley Fool UK has now become an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. We’ll be introducing a new name and brand over the coming weeks — we're very excited to share it with you and embark on this new chapter together!

3 big yielders I’d buy and hold for the next 5 years

Royston Wild runs the rule over three London-quoted dividend heroes.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

With data from the housing industry continuing to surpass expectations, I reckon Taylor Wimpey (LSE: TW) remains a great dividend stock to buy and hang onto well into the future.

Latest Bank of England data showed mortgage approval for property purchases galloping to 11-month highs in January, up 2.4% from December levels, to 69,928, again confounding predictions of a slump in homebuyer appetite.

And Taylor Wimpey itself lauded the strength of the domestic homes market this week. The builder commented that “UK housing market fundamentals remain good with strong customer confidence in our core geographies,” adding that “the market is underpinned by a competitive mortgage market and low interest rates.”

Despite fresh rhetoric from the government in the form of a recent white paper, hard action to address the country’s massive housing imbalance remains elusive, and this should continue to power shareholder returns at the likes of Taylor Wimpey.

With earnings therefore expected to keep rising at the firm, the City has chalked-in dividends of 13.8p and 14.9p per share in 2017 and 2018 respectively, yielding 7.5% and 8%. I reckon the Taylor Wimpey should be on the radar of all serious dividend searchers.

The perfect payout pill?

The exceptional progress of GlaxoSmithKline’s (LSE: GSK) R&D teams convinces me that the pharma ace should deliver increasingly-handsome dividends in the years to come.

The company has kept the dividend locked at 80p per share since 2014 as it has invested heavily in its product pipeline and tackled the problems of critical patent expirations. And the City expects GlaxoSmithKline to make good on its pledge to keep payouts around this level until the end of this year. This creates a bumper 4.8% yield.

And as the firm’s suite of new earnings drivers flies off the shelves — new product sales rocketed to £4.5bn during 2016 — the abacus bashers expect GlaxoSmithKline to get dividends moving higher again from 2018. An 80.3p per share reward is currently forecast, also yielding 4.8%.

And with it expecting test data on between 20 to 30 assets by the close of next year alone, I reckon the groundwork could be laid for spectacular earnings, and consequently dividend growth, further down the line.

Star in space

I also reckon Big Yellow Group (LSE: BYG) should keep churning out exceptional dividends as occupancy rates at its storage sites rise.

The business saw like-for-like revenues edge 5% higher during October-December, with demand for its lock-ups picking up following a difficult start to the quarter. While Big Yellow commented in January that “significant uncertainties remain around the UK’s economic outlook,” the company’s bias towards the South East and London should protect it from the worst of any bumpiness. Indeed, just under half of the firm’s facilities can be found within the M25.

The City certainly expects its rich record of profits growth to keep rolling and has consequently chalked-in dividends of 27.6p per share for the year to March 2017 and 30.1p for fiscal 2018. These figures yield 3.8% and 4.1% respectively, and I reckon the space star is in great shape to keep throwing out market-beating rewards.

Royston Wild has no position in any shares mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

British pound data
Investing Articles

2 UK shares to consider avoiding as the FTSE 100 extends losses

As the FTSE 100 dips for the second time this year, Mark Hartley weighs up market sentiment and considers two…

Read more »

Young brown woman delighted with what she sees on her screen
Investing Articles

How to invest £125 a month in UK shares to target a £39,039 annual passive income

Muhammad Cheema explains how an investor could earn the current median salary in the UK as passive income by making…

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

These white-hot FTSE 250 growth shares are on sale today!

Royston Wild loves a good bargain. Here he reveals two FTSE 250 shares that all savvy UK stock investors should…

Read more »

A senior man and his wife holding hands walking up a hill on a footpath looking away from the camera at the view. The fishing village of Polperro is behind them.
Investing Articles

How much do you need an ISA for a £31,352 second income?

Investing regularly in a Stocks and Shares ISA can generate a significant second income in retirement. Royston Wild explains how.

Read more »

Aston Martin DBX - rear pic of trunk
Investing Articles

With the Aston Martin share price in pennies, is it in bargain territory?

With the Aston Martin share price at a fraction of what it once was, is it a bargain? Our writer…

Read more »

A hiker and their dog walking towards the mountain summit of High Spy from Maiden Moor at sunrise
Investing Articles

How I plan to lock in sustainable growth on the FTSE 100 in the coming years

Mark Hartley takes a sobering look at the future, and outlines a plan to target FTSE 100 sectors with lower…

Read more »

Close-up image depicting a woman in her 70s taking British bank notes from her colourful leather wallet.
Investing Articles

What are the FTSE’s most lucrative high-yield shares?

Our writer zooms in one one of a handful of high-yield FTSE 100 shares to explain why he thinks it…

Read more »

Businessman with tablet, waiting at the train station platform
Investing Articles

Why bother with a SIPP now rather than wait 10 years?

Interested in a SIPP but putting it off to give yourself time to think? Christopher Ruane explains why that could…

Read more »